Current Problems in Cancer RSS feed: Current Issue. Each bimonthly issue of Current Problems in Cancer presents a single-topic, in-depth discussion, usually focused on the integrated management of a particular type of cancer or on a problem faced in a wide variety of malignancies. Issues may explore a particular category of drugs, an emerging interventional technique, or rehabilitation/reconstruction. Extensive bibliographies allow readers to easily locate additional information on related topics. Current Problems in Cancer serves the wide spectrum of physicians who treat patients with neoplastic disease. 2010 Topics , Volume 34, Issues 1-6 January Merkel Cell Carcinoma March Hepatocellular Carcinoma May American College of Radiology Appropriateness Criteria July Proton Therapy September Thymic Neoplasms November Combined Modality Therapy for Midface Lesions http://www.cpcancer.com/?rss=yesElsevier Inc.en © 2010 Published by Elsevier Inc. All rights reserved. Current Problems in Cancer0147-0272344July 2010 © 2010 Published by Elsevier Inc. All rights reserved. healthpermissions@elsevier.comhttp://www.cpcancer.com/article/PIIS014702721000067X/abstract?rss=yesTitle Page10.1016/S0147-0272(10)00067-XCurrent Problems in Cancer 34, 4 (2010)2010-07-01Current Problems in Cancer2010-07-01344S0147-0272(10)X0006-X251251http://www.cpcancer.com/article/PIIS0147027210000681/abstract?rss=yesInformation for Readers10.1016/S0147-0272(10)00068-1Current Problems in Cancer 34, 4 (2010)2010-07-01Current Problems in Cancer2010-07-01344S0147-0272(10)X0006-X252252http://www.cpcancer.com/article/PIIS0147027210000693/abstract?rss=yesTable of Contents10.1016/S0147-0272(10)00069-3Current Problems in Cancer 34, 4 (2010)2010-07-01Current Problems in Cancer2010-07-01344S0147-0272(10)X0006-X253254http://www.cpcancer.com/article/PIIS014702721000070X/abstract?rss=yesAuthor Bio Sketch10.1016/S0147-0272(10)00070-XCurrent Problems in Cancer 34, 4 (2010)2010-07-01Current Problems in Cancer2010-07-01344S0147-0272(10)X0006-X255255http://www.cpcancer.com/article/PIIS0147027210000644/abstract?rss=yesFrequently the Journal devotes issues to new technology in drug development or surgical/radiotherapy techniques. The impact of such advances may be subtle or immense, immediate or delayed. In the case of proton therapy, all may be claimed. Yet the jury remains out on the therapy's ultimate role in the Health Care Universe of the future. The technology has been available at limited sites for decades. However, the advent of new vendors and venture capital has contributed to several new facilities being built, with more on the way. Although protons do have some advantages over conventional radiotherapy, the increased cost for similar results in most tumors renders it “nice to have” in the clinic, but often highly coveted by institutions.ForewordPeter A.S. Johnstone10.1016/j.currproblcancer.2010.05.001Current Problems in Cancer 34, 4 (2010)2010-07-01Current Problems in Cancer2010-07-01344S0147-0272(10)X0006-X256256http://www.cpcancer.com/article/PIIS0147027210000528/abstract?rss=yesMedical treatment with protons was first proposed by famed American physicist Robert R. Wilson in a 1946 manuscript. Wilson recognized that the unique physical properties of protons would have distinct advantages over the photon (x-ray) radiation still used in the vast majority of radiation treatments delivered today. Researchers at Lawrence Berkeley National Laboratory in California treated the first patients with proton therapy and reported the first series of patients so treated in 1958. More than half a century later, after many years of seminal work in a limited number of institutions, proton therapy is now flourishing in the USA and abroad with over a dozen centers in operation and many more planned.Proton TherapyMark W. McDonald, Markus M. Fitzek10.1016/j.currproblcancer.2010.04.008Current Problems in Cancer 34, 4 (2010)2010-07-01Current Problems in Cancer2010-07-01344S0147-0272(10)X0006-X257296